title: Evidence and desperation in off-label prescribing: recombinant factor VIIa.
authors.affiliation: Australian Institute of Health Innovation, University of New South Wales, Sydney, NSW 2052, Australia. w.lipworth@unsw.edu.au
authors.forename: Wendy
authors.initials: W
authors.lastname: Lipworth
authors.forename: Ian
authors.initials: I
authors.lastname: Kerridge
authors.forename: Miles
authors.initials: M
authors.lastname: Little
authors.forename: Richard
authors.initials: R
authors.lastname: Day
mesh_terms: D003029:Coagulants / Q000627:therapeutic use*; D016527:Drug Costs; D019317:Evidence-Based Medicine; D015942:Factor VIIa / Q000191:economics / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D056687:Off-Label Use / Q000941:ethics
chemical_list: D003029:Coagulants; D015942:Factor VIIa